OpenAI expands Claude for Life Sciences with Biomni and MozzareLLM
Action Required
Scientists can accelerate research and discovery through the use of Claude and its integrated tools, leading to faster insights and potentially new scientific breakthroughs.
AI Impact Summary
OpenAI is expanding the capabilities of Claude with new tools and integrations, specifically targeting the life sciences sector. The launch of Biomni and the Cheeseman Lab's MozzareLLM demonstrate how Claude can accelerate scientific workflows by automating data analysis, hypothesis generation, and experimental design. This capability has the potential to significantly reduce the time and cost associated with scientific research, particularly in areas like genomics and drug discovery.
Affected Systems
- Date
- 15 Jan 2026
- Change type
- capability
- Severity
- high